The sample size was increased from 160 to 199 since the result with the enrolled 160 patients did not reach statistical significance.
← all excerpts
Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir.
1
—
—